About us Contacts Drug interactions: 390 212
Drug search by name

Fosamprenavir and Nevirapine Oral Suspension

Determining the interaction of Fosamprenavir and Nevirapine Oral Suspension and the possibility of their joint administration.

Check result:
Fosamprenavir <> Nevirapine Oral Suspension
Relevance: 21.07.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using nevirapine together with fosamprenavir may decrease the effects of fosamprenavir. Contact your doctor if your condition changes. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

ADJUST DOSE: Coadministration with nevirapine may significantly decrease the plasma concentrations of most protease inhibitors (PIs) except ritonavir. The mechanism is nevirapine induction of PI metabolism via CYP450 3A4. In seven patients with advanced HIV disease who were starting dual nucleoside analogs and nelfinavir (750 mg three times a day) as salvage therapy, mean nelfinavir peak plasma concentration (Cmax), 8-hour area under the concentration-time curve (AUC) and trough plasma concentration (Cmin) decreased by 43%, 50% and 53%, respectively, following addition of nevirapine 3 days later (200 mg daily for 2 weeks followed by 200 mg twice daily for 1 week). The time to reach Cmax was reduced from 4 to 2 hours. Autoinduction of nelfinavir metabolism may have played a role, as supported by a study involving 23 patients in which pre- and post-nevirapine plasma levels of nelfinavir taken presumably after both drugs have reached steady state demonstrated no evidence of a significant pharmacokinetic interaction. In another study, nevirapine decreased the median steady-state Cmax, AUC and Cmin of indinavir (800 mg three times a day) by 11%, 27% and 47%, respectively, after 4 weeks of coadministration in 17 HIV-infected subjects. However, antiretroviral response was significantly greater following addition of nevirapine. Ritonavir added as a pharmacokinetic booster has been shown to counteract the inductive effect of nevirapine in some cases, although a decrease in lopinavir concentrations was demonstrated in a pediatric study involving Kaletra and nevirapine.

MANAGEMENT: Given the risk of reduced viral susceptibility and resistance development associated with subtherapeutic antiretroviral drug levels, caution is advised if nevirapine is prescribed in combination with PIs, particularly if only one PI is used in the antiretroviral regimen. PI dosages may need to be increased when coadministered with nevirapine, although appropriate dosages with respect to safety and efficacy have not been established.

References
  • "Product Information. Lexiva (fosamprenavir)." GlaxoSmithKline, Research Triangle Park, NC.
  • Back D, Gibbons S, Khoo S "Pharmacokinetic drug interactions with nevirapine." J Acquir Immune Defic Syndr 34 Suppl 1 (2003): S8-14
  • "Product Information. Agenerase (amprenavir)." Glaxo Wellcome, Research Triangle Pk, NC.
  • Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12
  • Merry C, Barry MG, Mulcahy F, Ryan M, Tjia JF, Halifax KL, Breckenridge AM, Back DJ "The pharmacokinetics of combination therapy with nelfinavir plus nevirapine." AIDS 12 (1998): 1163-7
  • Barry M, Mulcahy F, Merry C, Gibbons S, Back D "Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection." Clin Pharmacokinet 36 (1999): 289-304
  • Skowron G, Leoung C, Kerr B, Dusek A, Anderson R, Beebe S, Grosso R "Lack of pharmacokinetic interaction between nelfinavir and nevirapine." AIDS 12 (1998): 1243-4
  • Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9
  • Mulcahy F, Barry M, Merry C, Back D "Nelfinavir and nevirapine interaction?" AIDS 12 (1998): 2361
  • Murphey RL, Sommadossi JP, Lamson M, Hall DB, Myers M, Dusek A "Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1." J Infect Dis 179 (1999): 1116-23
  • "Product Information. Viramune (nevirapine)." Boehringer-Ingelheim, Ridgefield, CT.
Fosamprenavir

Generic Name: fosamprenavir

Brand name: Lexiva, Telzir

Synonyms: n.a.

Nevirapine Oral Suspension

Generic Name: nevirapine

Brand name: Viramune, Viramune XR

Synonyms: Nevirapine

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle